Clinical trials · Oregon
Waldenstrom Macroglobulinemia clinical trials in Oregon
We’re tracking 3 recruiting waldenstrom macroglobulinemia studies with a site in Oregon — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Oregon
- NCT04840602RecruitingPhase 2
Venetoclax plus rituximab versus standard Waldenstrom treatment
This trial tests whether adding venetoclax to rituximab works better than standard treatment options for Waldenstrom’s macroglobulinemia (WM). It’s for adults whose WM needs treatment and who meet specific blood, organ, infection, and medication safety requirements.
Clackamas, OregonAges 18 years+ - NCT05544019RecruitingPhase 1
Testing an investigational drug for mature B-cell cancers
This early (Phase 1) study tests SGR-1505, an experimental treatment, in people with certain mature B-cell cancers. It’s mainly designed to see how the drug works in the body and to check safety, and it may offer an option if standard treatments aren’t enough.
Portland, OregonAges 18 years+ - NCT01804686RecruitingPhase 3
Long-term ibrutinib follow-up with or without nivolumab
This study looks at how safe and effective ibrutinib is over the long term, either alone or together with nivolumab. You may join if you are already in an earlier ibrutinib study and your care team feels staying on ibrutinib is worth the risk.
Eugene, OregonAges 18 years+
Waldenstrom Macroglobulinemia trials by city in Oregon
Where these studies are running in Oregon
Institutions with a site for the recruiting waldenstrom macroglobulinemia studies listed above.
- Kaiser Permanente Northwest
- Oregon Health & Science University (OHSU) - Knight Cancer Institute
- Providence Cancer Institute Clackamas Clinic
- Providence Newberg Medical Center
- Providence Portland Medical Center
- Providence Saint Vincent Medical Center
- Providence Willamette Falls Medical Center
- Willamette Valley Cancer Institute and Research Center
What taking part in a waldenstrom macroglobulinemia study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Waldenstrom Macroglobulinemia trials in other states
Common questions
- Are there waldenstrom macroglobulinemia clinical trials in Oregon?
- Yes. We're currently tracking 3 recruiting waldenstrom macroglobulinemia studies with a site in Oregon, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a waldenstrom macroglobulinemia study in Oregon?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Oregon to take part?
- Not necessarily. These studies have a site in Oregon, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a waldenstrom macroglobulinemia trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New waldenstrom macroglobulinemia studies open in Oregon regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.